“chemotherapy” Archives

in
Entry Author Date Location
MorphoSys, Incyte Get Early FDA Nod for Antibody Alternative to CAR-T 08/03/20 Europe
Gilead Gets Another CAR-T Approval, This Time for Mantle Cell Lymphoma 07/24/20 San Francisco
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Jazz Pharma Gets Quick FDA OK for New Small Cell Lung Cancer Drug 06/15/20 National
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
War Paint to Bone Paint: MIT Spinout Aims to Transform Regenerative Meds 04/21/20 Boston
Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs 04/17/20 Texas
UroGen Gets FDA Nod for Low-Grade Upper Tract Urothelial Cancer Drug 04/15/20 New York
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Gilead Boosts Cancer Drug Pipeline With $4.9B Deal for Forty Seven 03/02/20 San Francisco
United Therapeutics Drug Flunks Small Cell Lung Cancer Clinical Trial 02/03/20 National
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus 01/29/20 Boston
Epizyme’s Soft Tissue Cancer Drug Granted Speedy FDA Approval 01/23/20 Boston
Incyte Commits $900M to MorphoSys for Rights to Lymphoma Drug 01/13/20 National
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck 12/04/19 San Francisco
Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3 11/04/19 San Diego
With Ex-Medivation Exec Hung at Helm, Nuvation Nabs $275M for Cancer 10/28/19 New York
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More 10/18/19 National
Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test 10/16/19 Indiana
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street 10/03/19 National
Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38% 09/30/19 Raleigh Durham
Drug Pricing: Innovation, Investment, and the Public Good 09/24/19 Boston
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
Merck Data Are Another Step for Immunotherapy in Breast Cancer 07/29/19 New York
Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck 07/24/19 New York
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer 06/19/19 San Diego
Page 1 of 4 next page »